Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Compare the risk profiles of SP 500 versus bonds for retirees, highlighting diversification benefits and income stability.
21,457 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
Looking at Royal Caribbean in 2026, investors want clarity: is it a buy, hold, or sell? This guide breaks down the ca...
MercadoLibre's 2025 earnings reveal how a Latin American e-commerce and fintech leader is balancing growth with profi...
As TTEC heads into 2025 earnings season, investors want a clear view of what could drive the numbers. This guide brea...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
Cava shares surge upbeat after a brighter outlook from the fast-casual chain. This article breaks down what’s behind ...
Dubai's tax-free haven status is under pressure as Gulf tensions intensify following iran attacks dubai. The disrupti...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Budget models warn that trump’s strikes iran could carry a heavy price tag for taxpayers and households, with direct ...
Bitcoin trader and former BitMEX catalyst Arthur Hayes is sticking to a bold forecast: a multi-hundred-thousand-dolla...
A fresh $3.4 million investment in Northeast Bank by PMC FIG Opportunities highlights growing interest in regional le...